加入收藏 | ENGLISH

心血管科

当前位置: >> 科室设置 >> 临床科室 >> 心血管科 >> 论文论著 >>

心血管重点学科论文论著

发布时间:2016-03-06 01:57 浏览量:
 1.研究方向
  1. 冠心病心绞痛病证结合诊断标准及疗效评价研究
部分相关文章:
SCI收录论文
[1]Xiong XJ,Wang Z,Wang J.Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine. Curr Vasc Pharmacol.2015;13(4):540-53.
[2]Yang GY,Wang LQ,Ren J,et al Evidence base of clinical studies on Tai Chi: a bibliometric analysis. PLoS One.2015 Mar 16;10(3):e0120655.
[3]Wang JYu G. Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches. Chin J Integr Med. 2014 Mar;20(3):163-9.
[4]Chu FY, Yan X, Zhang Z, Xiong XJ, Wang J, Liu HX. Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional study. BMC Complementary and Alternative Medicine. 2013; 13: 287.
[5]Wang J, Xiong XJ, Feng B. Effect of crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 149363, 1-16.
[6]Yang XC, Xiong XJ, Wang HR, Yang GY, Wang J. Xuesaitong soft capsule (Chinese patent medicine) for the treatment of unstable angina pectoris: a meta-analysis and systematic review. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 948319, 1-7.
[7]Wang J, Xiong XJ, Feng B. Cardiovascular effects of salvianolic acid B. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 247948,1-16.
[8]Wang J, Wang PQ, Xiong XJ. Current situation and re-understanding of syndrome and formula syndrome in Chinese medicine. Internal Medicine. 2012; 2: Article ID 1000113, 1-5.
[9]Yanwei Xing, Janxin Chen, Jie Wang, et al. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. Journal of Ethnopharmacology. 2012;141(2):674-84.
[10]Yao Kuiwu, He Qingyong, Wang Jie, et al, Logistic Regression Analysis of Syndrome Essential Factors in Patients with Unstable Angina Pectoris. Journal of Traditional Chinese Medicine, 2011;31(4):273-6.
[11]Wang Jie, Zhang Yun, Guo Lili, et al. Salvianolic Acid B Inhibits the TLR4-NFκ B-TNFα Pathway and Attenuates Neonatal Rat Cardiomyocyte Injury Induced by Lipopolysaccharide. Chinese Journal of Integrative Medicine,2011,17(10):775-9.
[12]Wang Jie,He Qing-yong.  How to Construct the System of TCM Efficacy Evaluation for Coronary Heart Disease Angina Pectoris.  Chin J Integr Med,2010;16(1):75-78.
[13]Kuiwu Yao, Fu-Yong Chu, Jie Wang. A clinical epidemiological study of the quantitative diagnosis scale of blood stasis syndrome. Chin J Integr Med. 2011;17(3): 200-204.
[14]He Qing-yong,Wang Jie,Zhang Yun-ling, et al.  Effect of Yiqi Yangyin Decoction on Quality of Life in Patients with Unstable Angina Pectoris. Chin J Integr Med,2010;16(1):13-18.
[15]YAO Kui-wu, HE Qing-yong, TENG Fei, et al. Logistic Regression Analysis of Syndrome Essential Factors in Patients with Unstable Pectoris. Journal of Chinese Medicine. 2011,31(4):273-276.
[16]WU Min,Wang Jie,LIU Long-tao.Advance of Studies on Anti-atherosclerosis Mechanism of Berberine.Chin J Integr Med,2010;16(2):188-192.
[17]Fu-Yong Chu, Jie Wang, Kui-Wu Yao, et al. Effects of Xuefu Zhuyu Capsule on Symptoms and Signs, Health-related Quality of Life in Unstable Angina Patients with Blood-stasis Syndrome after Percutaneous Coronary Intervention: A Randomized Controlled Trial. Chin J Integr Med. 2010;16(3): 399-405.
②中文核心期刊
[1]袁蓉,王阶,郭丽丽. 睡眠剥夺对冠心病的影响及中医药防治进展[J]. 中国中药杂志,2015,09:1666-1669.
[2]廖江铨,刘咏梅,王阶. 1ncRNA与miRNA相互调控作用及与心血管疾病的关系[J]. 临床心血管病杂志,2015,03:234-237.
[3] 林飞,王阶,郭丽丽,袁蓉,何永侠. 中医药对冠心病经皮冠状动脉介入术后治疗现状研究[J]. 中华中医药杂志,2015,04:1181-1183.
[4]廖江铨,刘咏梅,王阶. lncRNA与miRNA相互调控作用及与心血管疾病的关系[J]. 临床心血管病杂志,2015,03:234-237.
[5]林飞,王阶,郭丽丽,袁蓉,何永侠. 中医药对冠心病经皮冠状动脉介入术后治疗现状研究[J]. 中华中医药杂志,2015,04:1181-1183.
[6]王阶,郭丽丽. 病证结合多目标优化提高防治冠心病新药研究水平[J]. 中国中药杂志,2015,17:3402-3405.
[7]廖江铨,刘咏梅,王阶. miRNA在冠心病诊断和治疗中的研究进展[J]. 中国科学:生命科学,2015,08:748-754.
[8]王阶,郭丽丽. 病证结合多目标优化提高防治冠心病新药研究水平[J]. 中国中药杂志,2015,17:3402-3405.
[9]滕菲,王阶. 血塞通治疗冠心病心绞痛随机对照试验的质量评价[J]. 北京中医药,2014,12:930-933.
[10]何庆勇,王阶,姚魁武,朱明军,马长生,叶勇,王永霞,林谦,衷敬柏,汤艳莉,熊兴江,荆鲁,农一兵. 以证候要素为内容的冠心病心绞痛中医疗效评价体系研究[J]. 中华中医药杂志,2014,12:3809-3814.
[11]王淑丽,王阶,冯玲,杨戈,任丽. 冠脉临界病变的中医证候文献回顾与分析[J]. 环球中医药,2014,11:896-900.
[12]褚福永,王阶,刘红旭,李志忠. 不稳定型心绞痛冠脉介入期间中医证候动态演变规律研究[J]. 中华中医药杂志,2013,03:627-630.
[13]段练,熊兴江,王阶. 冠心病的治疗性血管新生与活血化瘀[J]. 中国中西医结合杂志,2013,11:1561-1566.
[14]王阶,虞桂. microRNA与冠心病中医证候研究[J]. 中国中西医结合杂志,2012,11:1562-1565.
[15]王阶,熊兴江,张兰凤. 病证结合模式及临床运用探索. 中国中西医结合杂志,2012,32(3).
[16]李小可,王阶,熊兴江. 中医学的经验基础论特征探讨. 中医杂志,2012,53(5).
[17]刘咏梅,虞桂,王阶,. microRNA与心血管疾病 . 中国分子心脏病学杂志,2011,(6).
[18]赵志宏,邢雁伟,王阶,. 冠心病心气虚证与冠脉病变及心功能不全关系分析 . 中西医结合心脑血管病杂志,2011,17(11).
[19]熊兴江,王阶,. 血府逐瘀汤方证特征 . 中国中药杂志,2011,19(21).
[20]王阶,张云,郭丽丽,等,. Salvianolic Acid B Inhibits the TLR4-NFκ B-TNFα Pathway and Attenuates Neonatal Rat Cardiomyocyte Injury Induced by Lipopolysaccharide . Chinese Journal of Integrative Medicine,2011,18(10).
[21]任丽,王阶,冯玲,等. 64层CTA结合血清MMP-9、sCD40L评价冠脉临界病变斑块成分及稳定性 . 心脏杂志,2011,(6).
[22]任丽,王阶,冯玲,等. 冠状动脉临界病变患者血清MMP-9、sCD40L水平及其临床意义 . 临床心血管病杂志,2011,(9).
[23]何庆勇,王阶,朱明军,等. 基于冠心病心绞痛患者报告临床结局评价量表的条目筛选分析 . 中华中医药杂志,2010,(12).
 
2)心系疾病有效药物组分配伍的研究
⑤国家中医药管理局行业专项——《基于临床科研信息共享系统的真实世界冠心病诊疗方案研究》35万   (2012-2013)  负责人:李军
相关成果:
①研究获专利:一种用于预防和治疗心血管疾病的药物组合物及其用途  ,专利号:201210014714.9;
②研究获专利:一种用于治疗冠心病的药物组合物及其制备方法,专利号:201110003790.5。
 
部分相关文章:
①SCIEI收录论文
[1]Min Li, Qingyong He, Yinfeng Chen, et al. Xuezhikang Capsule for Type 2 Diabetes withHyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails[J].Evidence-Based Complementary and Alternative Medicine, 2015, Article ID 468520.
[2]Yang XXiong XYang GWang J.Chinese patent medicine Xuefu Zhuyu capsule for the treatment ofunstable angina pectoris: A systematic review of randomized controlled trials. Complement Ther Med. 2014 Apr;22(2):391-9.
[3]Wei Cao, Guo Xiaowen, WANG Jie, et al. Inhibition of hypoxia and serum deprivation-induced apoptosis by salvianolic acid in rat mesenchymal stem cells. Journal of Traditional Chinese Medicine. 2012; 32(2): 274-280.
[4]Wei Cao, Guo Xiaowen, WANG Jie, et al. Current Progress of Research on Pharmacologic Actions of Salvianolic Acid B. Chin J Integr Med. 2012; 16(4): 274-280.
[5]WANG Jie, ZHANG Yun, GUO Lili, et al. Salbianolic Acid B Inhibits the TLR4-NFκB-TNFαPathway and Attenuates Neonatal Rat Cardiomyocyte Injury Induced by Lipopolysaccharide[J]. Chinese Journal of Integrative Medicine,2011,17(10):775-780.
[6]Yanwei Xing, Janxin Chen, Jie Wang, et al. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. Journal of Ethnopharmacology. 2011, doi: 10.1016/j.jep. 2011.08.051.
[7]WU Min,Wang Jie,LIU Long-tao.Advance of Studies on Anti-atherosclerosis Mechanism of Berberine.Chin J Integr Med,2010;16(2): 188-192.
②中文核心期刊
[1]安宇,王阶,李赵陵. 中药新药临床疗效评价的现状与发展[J]. 中华中医药杂志,2015,01:9-11.
[2]安宇,王阶,何庆勇,李赵陵. 对中药新药研发的思考[J]. 中国中医药信息杂志,2014,04:1-2.
[3]郭丽丽,王阶,林飞,何永侠. 丹蒌片对短暂心肌缺血再灌注诱导的心律失常模型大鼠的保护作用及机制[J]. 中国中西医结合杂志,2014,09:1125-1129.
[4]张云,王阶,郭丽丽,吴广均. 活血安心方减轻急性心肌梗死大鼠心肌过氧化损伤的实验研究[J]. 中国中西医结合杂志,2013,10:1356-1360.
[5]张云,王阶,郭丽丽,等. 活血安心方减轻急性心肌梗死大鼠心肌缺血损伤的实验研究. 中国中西医结合杂志,2012,32(7).
[6]陈雯,郭丽丽,王阶. 中药防治心肌缺血再灌注损伤研究进展. 辽宁中医,2012,39(6).
[7]郭丽丽,王阶,陈雯,等. 制备大鼠离体心脏损伤模型的最佳缺血再灌注时间. 中国药理学与毒理学杂志,2012,(3).
[8]张云,王阶,蒋跃文,等. 活血药合用安神药对急性心肌梗死大鼠心肌损伤的保护作用. 中国中药杂志,2012,(7).
[9]张云,王阶,吴广均,等. 丹参酚酸B抑制TLR4-NFκB-TNFα炎症损伤通路防治心肌细胞的缺氧损伤. 辽宁中医,2012,39(1):20-23.
[10]刘咏梅,虞桂,王阶. microRNA与心血管疾病 . 中国分子心脏病学杂志,2011,(6).
[11]张翠英,刘峰,郭丽丽,等. 酸枣仁醇提物中4个活性成分的测定 . 中成药,2011,(12).
[12]熊兴江,王阶. 论高血压病的中医认识及经典名方防治策略 . 中医杂志,2011,42(23).
[13]赵志宏,邢雁伟,王阶. 冠心病心气虚证与冠脉病变及心功能不全关系分析 . 中西医结合心脑血管病杂志,2011,17(11).
[14]陈雯,郭丽丽,周婷婷,等. 丹参总酚酸对离体心脏缺血再灌注损伤的保护作用 . 中国实验方剂学杂志,2011,(9).
[15]崔翰明,张秋燕,彭亮. 三七不同部位及总皂苷提取物HPLC指纹图谱研究 . 中药材,2011,(3).
[16]任丽,王阶,冯玲,等. 冠脉易损斑块的中医病机治法探讨 . 中华中医药学刊,2011,(2).
[17]董宇,王阶,杨庆,等. CYP450酶与中药代谢相互作用关系研究概况 . 中国中医药信息杂志,2011,(1).
[18]陈雯,黄世敬. 酸枣仁化学成分及药理作用研究进展 . 时珍国医国药,2011,(7).
[19]王玉磊,黄世敬,迟德军,等. 巴戟天中主要环烯醚萜苷的稳定性研究 . 中国实验方剂学杂志,2011,(21).
[20]王玉磊,崔翰明,黄世敬,等. HPLC测定不同产地和批次巴戟天中主要环烯醚萜苷含量 . 中药材,2011,(8).
[21]汪艳丽,刘如秀,刘志明,等. 通阳活血方对50例慢性心衰患者BNP及心功能的影响 . 辽宁中医杂志,2010,(8).
 
3)高血压病的防治研究
部分相关文章:
SCI收录论文
[1] X. Xiong, X. Li, Y. Zhang and J. Wang. Chinese herbal medicine for resistant hypertension: a systematic review[J]. BMJ Open 2015, 5(1): e005355.
[2] J. Wang, X. Xiong and B. Feng. Aspirin resistance and promoting blood circulation and removing blood stasis: current situation and prospectives[J]. Evid Based Complement Alternat Med 2014, 2014: 954863.
[3] X. Yang, H. Zhao and J. Wang. Chinese massage (Tuina) for the treatment of essential hypertension: a systematic review and meta-analysis[J]. Complement Ther Med 2014, 22(3): 541-8.
[4] J. Wang, X. Xiong and X. Yang. Is it a new approach for treating senile hypertension with kidney-tonifying chinese herbal formula? A systematic review of randomized controlled trials[J]. Evid Based Complement Alternat Med 2014, 2014: 473038.
[5] Wang J, Xiong XJ, Liu W. Acupuncture for essential hypertension. International Journal of Cardiology. 2013,169; 5: 317-326.
[6] Wang J, Feng B, Xiong XJ. Chinese herbal medicine for the treatment of obesity-related hypertension. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 757540, 1-11.
[7] Wang J, Xiong XJ, Liu W. Yoga for essential hypertension: a systematic review. PLoS ONE. 8; 10: e76357.
[8] Wang J, Feng B, Yang XC, Liu W, Teng F, Li S, Xiong XJ. Tai Chi for essential hypertension. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 215254, 1-10.
[9] Wang J, Feng B, Yang XC, Liu W, Xiong XJ. Chinese herbal medicine for the treatment of prehypertension. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 493521, 1-9.
[10] Xiong XJ, Yang XC, Liu W, Chu FY, Wang PQ, Wang J. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 275279, 1-13.
[11] Wang J, Xiong XJ, Yang GY, Zhang YQ, Liu YM, Zhang Y, Zhang ZP, Li J, Yang XC. Chinese herbal medicine qi ju di huang wan for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 262685, 1-10.
[12]Wang J, Xiong XJ. Evidence-based Chinese medicine for hypertension. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 978398, 1-12.
[13]Wang J, Feng B, Yang XC, Liu W, Liu YM, Zhang Y, Yu G, Li SJ, Zhang YQ, Xiong XJ. Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 706125, 1-18.
[14]Xiong XJ, Yang XC, Liu YM, Zhang Y, Wang PQ, Wang J. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertension Research. 2013; 36: 570-579.
[15]Xiong XJ, Yang XC, Feng B, Liu W, Duan L, Gao A, Li HX, Ma JZ, Du XL, Li N, Wang PQ, Su KL, Chu FY, Zhang GH, Li XK, Wang J. Zhen gan xi feng decoction, a traditional Chinese herbal formula, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 982380, 1-9.
[16]Xiong XJ, Liu W, Yang XC, Feng B, Wang J. Moxibustion for essential hypertension. Complementary Therapies in Medicine. 2014; 22: 187-195.
[17]Yang XC, Xiong XJ, Yang GY, Wang J. Effectiveness of moxibustion on acupoint KI 1 for the treatment of essential hypertension: a systematic review of randomized controlled trials?. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 187484, 1-10.
[18]Wang J, Yang XC, Feng B, Qian WD, Fang ZY, Liu W, Li HX, Li XK, Chu FY, Xiong XJ. Is Yangxue Qingnao Granule combined with antihypertensive drugs, a new integrative medicine therapy, more effective than antihypertensive therapy alone in treating essential hypertension?. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: Article ID 540613, 1-8.
[19]Wang J, Xiong XJ. Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine. 2012; 2012: Article ID 697237, 1-10.
[20]Xiong XJ, Yang XC, Liu W, Feng B, Ma JZ, Du XL, Wang PQ, Chu FY, Wang J. Banxia baizhu tianma decoction for essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2012; 2012: Article ID 271462, 1-10.
[21]Wang J, Yao KW, Yang XC, Liu W, Feng B, Ma JZ, Du XL, Wang PQ, Xiong XJ. Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine. 2012; 2012: Article ID 714805, 1-7.
[22]Wang J, Xiong XJ. Control strategy on hypertension in Chinese medicine. Evidence-Based Complementary and Alternative Medicine. 2012; 2012: Article ID 284847, 1-6.
[23]WU Min,Wang Jie,LIU Long-tao.Advance of Studies on Anti-atherosclerosis Mechanism of Berberine.Chin J Integr Med,2010;16(2):188-192.
[24]Wei Cao, Guo Xiaowen, WANG Jie, et al. Inhibition of hypoxia and serum deprivation-induced apoptosis by salvianolic acid in rat mesenchymal stem cells. Journal of Traditional Chinese Medicine. 2012; 32(2): 274-280.
[25]Duan Lian, Xiong Xingjiang, Liu Yongmei, Wang jie. miRNA-1: functional roles and dysregulation in heart disease. Molecular BioSystems. 2014. 10, 2775.
 
中文核心期刊
[1]陈中,王阶,李俊平. 针刺治疗高血压病的研究进展[J]. 中华中医药杂志,2015,09: 210-3214.
[2]段练,熊兴江,王阶. 血压波动性及中医药研究进展[J]. 中华中医药杂志,2015,01: 174-177.
[3]段练,熊兴江,王阶. MicroRNA与高血压病[J]. 中国中药杂志,2014,03:397-401.
[4]熊兴江,王阶. 经典名方治疗高血压病临床实践[J]. 中国中药杂志,2014,05:929-933.
[5]杨晓忱,熊兴江,王阶. 补肾方药治疗高血压病伴胰岛素抵抗进展[J]. 中国中西医结合杂志,2014,05:637-640.
[6]刘巍,熊兴江,王阶. 高血压病代谢紊乱及化浊平肝法的临床运用. 中国中药杂志. 2013,38(8): 1251-1254.
[7] 熊兴江,王阶. 经方在高血压病治疗中的运用[J]. 中国中药杂志,2013,11:1836-1839.
[8]杨晓忱,熊兴江,张云,刘咏梅,王阶. 补肾降压方对自发性高血压大鼠脂联素及胰岛素抵抗的影响[J]. 世界中西医结合杂志,2013,11:1107-1110.
[9]刘巍,熊兴江,王阶. 高血压前期的中医认识及治疗[J]. 中国中药杂志,2013,14:2416-2420.
[10]熊兴江,王阶. 论高血压病的中医认识及经典名方防治策略. 中医杂志,2011,42(23).
[11]李海霞,赵志宏,宋庆桥,等. 厄贝沙坦氢氯噻嗪和富马酸比索洛尔联合治疗青年高血压[J]. 中华高血压杂志,2011,(4) : 324-328..
[12]熊兴江,王阶,何庆勇. 基于方证对应理念的减少药物不良反应思考[J]. 中国中药杂志,2010,23(4) :536-538..
[13]王阶,熊兴江. 名医经验传承探索之路[J]. 中医杂志,2011,(7) :545-549..
[14]姚魁武,张良登,王阶. 近5年部分核心期刊中医药治疗冠心病心绞痛随机对照试验的质量评价[J]. 北京中医药,2011,(3) :171-175.
[15]李小可,王阶. 人参汤方证病机释微[J]. 北京中医药大学学报,2011,(12) :808-809.
[16]周育平,安成,胡元会,等. 心肾综合征患者临床特征及中医证候特点分析[J]. 时珍国医国药,2010,(12) :3362-3363.
4)心力衰竭的防治研究
部分相关文章:
①SCI收录论文
[1] Xiangning Cui, Jian Zhang, Yubo Li, Yuxiu Sun, Jian Cao, Mingjing Zhao, Yizhou Zhao, Xin Zhao, Yaoyao He, Anbang Han. Effects of Qili Qiangxin Capsule on AQP2, V2R, and AT1R in Rats with Chronic Heart Failure. Evid Based Complement Alternat Med. 2015; 2015: 639450.
[2] Yu Chen, Xingjiang Xiong, Chunmei Wang, Chenggang Wang, Ying Zhang, Xingyong Zhang, Yonghong Gao, Yanhui Xing, Jun Li, Jie Wang, Xiaoqiu Liu, Yanwei Xing. The Effects of Wenxin Keli on Left Ventricular Ejection Fraction and Brain Natriuretic Peptide in Patients with Heart Failure: A Meta-Analysis of Randomized Controlled Trials. Evid Based Complement Alternat Med. 2014; 2014: 242589.
[3] Yu Chen, Yang Li, Lili Guo, Wen Chen, Mingjing Zhao, Yonghong Gao, Aiming Wu, Lixia Lou, Jie Wang, Xiaoqiu Liu, Yanwei Xing. Effects of Wenxin Keli on the Action Potential and L-Type Calcium Current in Rats with Transverse Aortic Constriction-Induced Heart Failure. Evid Based Complement Alternat Med. 2013; 2013: 572078.
[4] Yao Kuiwu, Zhang Liangdeng, Wang Jie. The use of autologous bone marrow stem cells mobilization in the treatment of heart failure with Chinese medicine. Chin J Integr Med,2011,17(7): 1-8.
[5] Yao Kuiwu, Zhang Liangdeng, Wang Jie. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine. Chin J Intergr Med 2011,17(11):873-880.
[6] Kui-wu Yao, Liang-deng Zhang, Jie Wang. The mobilization of autologous bone marrow stem cells in the treatment of heart failure with Chinese medicine.Chin J Integr Med. 2011, 17(11):873-80.
中文核心期刊
[1] 王欢,胡元会,魏艺,贾岱琳,杜柏. 冠心病慢性心力衰竭患者外周血CD4+CD25+Foxp3+Treg细胞的研究[J]. 中西医结合心脑血管病杂志,2015,01:33-36.
[2] 何庆勇. 《金匮要略》“血不利则为水”理论与顽固性心力衰竭的治疗[J]. 中华中医药杂志,2015,01:120-122.
[3] 张健,崔向宁,曹戬. 芪苈强心胶囊对改善慢性心力衰竭大鼠心功能及AQP-2表达的影响[J]. 中国实验方剂学杂志,2014,10:183-187.
[4] 杨艳玲,曹雪滨,解亚楠,王祥贺,何建成,张刚,胡元会,李俊峡. 缺血性心肌病心力衰竭气虚血瘀证患者特异性血清标志物研究[J]. 中医杂志,2014,07:567-570.
[5] 林飞,许娜,刘巍,王阶. 宗气、心力衰竭和能量代谢的相关性研究[J]. 北京中医药,2013,09:659-662.
[6] 胡元会,杜柏,方素萍,马铁民,冯玄超,姜北,杨正. 心复康口服液对心梗后心衰大鼠心肌组织CK-MM mRNA及蛋白表达的影响[J]. 中国实验方剂学杂志,2013,16:206-209.
[7] 赵鑫,崔向宁. 基于中医传承辅助系统的治疗慢性心力衰竭方剂组方规律分析[J]. 中国实验方剂学杂志,2012,19:8-11.
[8] 沈娟,王正,商秀洋,杜柏,宋庆桥. 缺血性心力衰竭阳虚证患者临床特征初探[J]. 中国中医急症,2012,05:708-709+737.
[9] 王艳飞,王红英,曹雪滨,任越,张刚,何建成,胡元会. 卡托普利对心力衰竭大鼠心肌细胞Bax、Bcl-2蛋白表达的影响[J]. 中国应用生理学杂志,2012,04:331-333.
[10] 汪艳丽,刘如秀,刘金凤,刘志明. 通阳活血方治疗慢性充血性心力衰竭的临床观察[J]. 中国中医基础医学杂志,2011,07:772-774.
[11] 汪艳丽,刘如秀,刘金凤,刘志明. 通阳活血方联合西药对慢性充血性心力衰竭患者血浆脑钠肽及6分钟步行试验的影响[J]. 中医杂志,2011,07:566-569.
 
5)心律失常的防治研究
部分相关文章:
[1] Wei Cao, Xiaowen Guo, Huzhan Zheng, Deping Li, Guanbo Jia, Jie Wang. Current Progress of Research on Pharmacologic Actions of Salvianolic Acid B. Chin J Integr Med. 2012; 16(4): 274-280.
[2] Ruxiu Liu, Yanli Wang, Huibo Li, Nina Wang, Meijing Bao, Liya Xu. Comparative study between original and traditional method in establishing a chronic sinus node damage model in rabbit.J Appl Physiol (1985). 2012;113(11):1802-8.
[3] 郑蕊,陈静,樊官伟,邢雁伟,商洪才. 潜在恶性心律失常治疗进展及中医药防治特点与前景[J]. 中医杂志,2015,18:1615-1618.
[4] 刘金凤,陈靖,童建霞,徐利亚,汪艳丽. 刘如秀治疗心房颤动经验解析[J]. 辽宁中医杂志,2015,09:1646-1649.
[5] 郭丽丽,王阶,林飞,何永侠. 丹蒌片对短暂心肌缺血再灌注诱导的心律失常模型大鼠的保护作用及机制[J]. 中国中西医结合杂志,2014,09:1125-1129.
[6] 刘宇,刘如秀. 钙离子/钙调蛋白依赖性蛋白激酶Ⅱ在心力衰竭与触发性心律失常中的信号转导作用[J]. 医学综述,2014,10:1750-1752.
[7]刘金凤,关宣可,徐利亚,陈靖,童建霞,汪艳丽. 刘如秀教授治疗室性早搏的经验解析[J]. 环球中医药,2014,08:598-600.
[8] 郭丽丽,王阶,陈雯,周婷婷. 制备大鼠离体心脏损伤模型的最佳缺血再灌注时间[J]. 中国药理学与毒理学杂志,2012,03:353-356.
[9] 刘如秀,李汇博,王妮娜,暴美静. 益阳活血方对兔病窦综合征心阳虚血瘀证模型中医证候及血液流变学的影响[J]. 中华中医药杂志,2011,09:2065-2068.
[10] 刘如秀,王妮娜,李汇博,暴美静,汪艳丽. 康心复律方对病态窦房节综合征家兔窦房结电生理功能影响[J]. 中国中西医结合杂志,2011,08:1118-1121.
[11] 展慧慧,刘如秀,刘金凤,刘志明. 强心复脉颗粒与西药对照治疗病态窦房结综合征101例[J]. 辽宁中医杂志,2011,04:665-666.